Enrique Martinez Bringas
Family Medicine · Moline, ILNPI 1124025531
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 335 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,683 and has fallen 71.1% since, to $487 in 2023. Among family medicine clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 335 payments — averaging $18.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$908
- AstraZeneca$702
- Lilly USA, LLC$683
- Sanofi-aventis U.S. LLC$602
- Amgen$592
- Boehringer Ingelheim$442
- plus $2K from 14 others
What the payments were for
- Food & beverage$6,126100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 47 | $908 |
| AstraZeneca | 41 | $702 |
| Lilly USA, LLC | 37 | $683 |
| Sanofi-aventis U.S. LLC | 33 | $602 |
| Amgen | 30 | $592 |
| Boehringer Ingelheim | 18 | $442 |
| Merck | 28 | $435 |
| Pfizer | 28 | $429 |
| AbbVie(2 entities) | 22 | $409 |
| Kowa Pharmaceuticals America, Inc. | 16 | $290 |
| Johnson & Johnson | 8 | $171 |
| Novartis | 8 | $150 |
| GSK | 4 | $77 |
| Shire North American Group Inc | 4 | $63 |
| Teva Pharmaceuticals USA, Inc. | 4 | $57 |
| Exact Sciences | 2 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $13 |
How this compares
$6,141 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan Potassium | 15 | $67 |
| Atorvastatin Calcium | 18 | $64 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Moline
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.